Induction of a Proinflammatory Response in Cortical Astrocytes by the Major Metabolites Accumulating in HMG-CoA Lyase Deficiency: the Role of ERK Signaling Pathway in Cytokine Release

[1]  M. Brenner.  Role of GFAP in CNS injuries , 2014, Neuroscience Letters.

[2]  A. Santamaría,et al.  Comparing the effects of two neurotoxins in cortical astrocytes obtained from rats of different ages: involvement of oxidative damage , 2014, Journal of applied toxicology : JAT.

[3]  G. Leipnitz,et al.  In vivo experimental evidence that the major metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency induce oxidative stress in striatum of developing rats: a potential pathophysiological mechanism of striatal damage in this disorder. , 2013, Molecular genetics and metabolism.

[4]  Jialin C. Zheng,et al.  IL‐1β and TNF‐α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase , 2013, Journal of neurochemistry.

[5]  André Quincozes-Santos,et al.  Characterization of Adult Rat Astrocyte Cultures , 2013, PloS one.

[6]  D. Souza,et al.  Resveratrol Prevents Ammonia Toxicity in Astroglial Cells , 2012, PloS one.

[7]  A. Quintana,et al.  Interleukin-6, a Major Cytokine in the Central Nervous System , 2012, International journal of biological sciences.

[8]  M. Norenberg,et al.  Primary Cultures of Astrocytes: Their Value in Understanding Astrocytes in Health and Disease , 2012, Neurochemical Research.

[9]  Peter W Zandstra,et al.  Systematic engineering of 3D pluripotent stem cell niches to guide blood development. , 2012, Biomaterials.

[10]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[11]  O. Kozawa,et al.  Midazolam suppresses interleukin-1β-induced interleukin-6 release from rat glial cells , 2011, Journal of Neuroinflammation.

[12]  M. Santello,et al.  TNFα Controls Glutamatergic Gliotransmission in the Hippocampal Dentate Gyrus , 2011, Neuron.

[13]  M. Wajner,et al.  Neurochemical evidence that 3-methylglutaric acid inhibits synaptic Na+,K+-ATPase activity probably through oxidative damage in brain cortex of young rats , 2011, International Journal of Developmental Neuroscience.

[14]  T. Kensler,et al.  When NRF2 talks, who's listening? , 2010, Antioxidants & redox signaling.

[15]  Yu Tian Wang,et al.  Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  O. Kozawa,et al.  Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells , 2010, Journal of Neuroinflammation.

[17]  J. O'Callaghan,et al.  Astrogliosis in CNS Pathologies: Is There A Role for Microglia? , 2010, Molecular Neurobiology.

[18]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[19]  J. Ezekowitz,et al.  A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency , 2009, Case reports in medicine.

[20]  G. Leipnitz,et al.  Striatum is more vulnerable to oxidative damage induced by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency as compared to liver , 2009, International Journal of Developmental Neuroscience.

[21]  C. Gottfried,et al.  The Janus Face of Resveratrol in Astroglial Cells , 2009, Neurotoxicity Research.

[22]  S. Reimão,et al.  3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Initial presentation in a young adult , 2009, Journal of Inherited Metabolic Disease.

[23]  A. Bordey,et al.  The astrocyte odyssey , 2008, Progress in Neurobiology.

[24]  S. Heales,et al.  Astrocytes Protect Against Copper-Catalysed Loss of Extracellular Glutathione , 2008, Neurochemical Research.

[25]  G. Leipnitz,et al.  Induction of oxidative stress by the metabolites accumulating in 3-methylglutaconic aciduria in cerebral cortex of young rats. , 2008, Life sciences.

[26]  G. Leipnitz,et al.  Evidence that 3‐hydroxy‐3‐methylglutaric acid promotes lipid and protein oxidative damage and reduces the nonenzymatic antioxidant defenses in rat cerebral cortex , 2008, Journal of neuroscience research.

[27]  B. Puisac,et al.  Molecular genetics of HMG-CoA lyase deficiency. , 2007, Molecular genetics and metabolism.

[28]  D. Zafeiriou,et al.  3-Hydroxy-3-methylglutaryl coenzyme a lyase deficiency with reversible white matter changes after treatment. , 2007, Pediatric neurology.

[29]  Sang Won Suh,et al.  Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. , 2007, The Journal of clinical investigation.

[30]  G. Burckhardt,et al.  3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate transporter NaDC3 , 2007, Journal of Molecular Medicine.

[31]  C. Farina,et al.  Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.

[32]  S. Legrand-Poels,et al.  NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .

[33]  C. Gottfried,et al.  Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. , 2006, Archives of biochemistry and biophysics.

[34]  G. Ekinci,et al.  Corticospinal tract involvement in a patient with 3-HMG coenzyme A lyase deficiency. , 2006, Pediatric neurology.

[35]  C. Harding,et al.  Intracerebral accumulation of glutaric and 3‐hydroxyglutaric acids secondary to limited flux across the blood–brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl‐CoA dehydrogenase deficiency , 2006, Journal of neurochemistry.

[36]  C. Darlington.  Astrocytes as targets for neuroprotective drugs. , 2005, Current opinion in investigational drugs.

[37]  Leif Hertz,et al.  Astrocytic control of glutamatergic activity: astrocytes as stars of the show , 2004, Trends in Neurosciences.

[38]  Stefan Kahlert,et al.  Glial perspectives of metabolic states during cerebral hypoxia--calcium regulation and metabolic energy. , 2004, Cell calcium.

[39]  G. Kaur,et al.  Impact of hypoglycemia and diabetes on CNS: Correlation of mitochondrial oxidative stress with DNA damage , 2004, Molecular and Cellular Biochemistry.

[40]  Toshio Matsuda,et al.  Astrocyte apoptosis: implications for neuroprotection , 2004, Progress in Neurobiology.

[41]  S. Goldman,et al.  New roles for astrocytes: Redefining the functional architecture of the brain , 2003, Trends in Neurosciences.

[42]  J. Zeman,et al.  Biochemical and molecular analyses in three patients with 3-hydroxy-3-methylglutaric aciduria , 2003, Journal of Inherited Metabolic Disease.

[43]  Robert M Friedlander,et al.  Apoptosis and caspases in neurodegenerative diseases. , 2003, The New England journal of medicine.

[44]  J. Saudubray,et al.  Branched-chain organic acidurias. , 2002, Seminars in neonatology : SN.

[45]  N. Urgancı,et al.  A rare cause of hepatomegaly: 3-hydroxy-3-methylglutaryl coenzyme-a lyase deficiency. , 2001, Journal of pediatric gastroenterology and nutrition.

[46]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[47]  R. Dringen,et al.  Metabolism and functions of glutathione in brain , 2000, Progress in Neurobiology.

[48]  R. Swanson,et al.  Astrocyte glutamate transport: Review of properties, regulation, and physiological functions , 2000, Glia.

[49]  T. Nakahata,et al.  Cerebral infarction and pancreatitis: possible complications of patients with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , 2000, Journal of Inherited Metabolic Disease.

[50]  C. Heizmann,et al.  Evaluation of urinary acylglycines by electrospray tandem mass spectrometry in mitochondrial energy metabolism defects and organic acidurias. , 2000, Molecular genetics and metabolism.

[51]  A. Dinçer,et al.  MRI and MRS in HMG-CoA lyase deficiency. , 1999, Pediatric neurology.

[52]  J. Lai,et al.  Functional studies in cultured astrocytes. , 1998, Methods.

[53]  J. Valk,et al.  MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency. , 1998, AJNR. American journal of neuroradiology.

[54]  M. Robert,et al.  Molecular prenatal diagnosis of 3‐hydroxy−3‐methylglutaryl coa lyase deficiency , 1995, Prenatal diagnosis.

[55]  M. Tsai,et al.  Differences in the disposition and toxicity of 1‐methyl‐4‐phenylpyridinium in cultured rat and mouse astrocytes , 1994, Glia.

[56]  R. Wanders,et al.  Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , 1994, Journal of Inherited Metabolic Disease.

[57]  J. T. Clarke,et al.  Pancreatitis in patients with organic acidemias. , 1994, The Journal of pediatrics.

[58]  T. Coşkun,et al.  3-Hydroxy-3-methylglutaryl coenzyme A lyase deficiency , 1993, Journal of Inherited Metabolic Disease.

[59]  R. Surtees,et al.  Physiology and pathophysiology of organic acids in cerebrospinal fluid , 1993, Journal of Inherited Metabolic Disease.

[60]  K. Gibson,et al.  3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients , 1988, European Journal of Pediatrics.

[61]  S. Wysocki,et al.  3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: A review , 1986, Journal of Inherited Metabolic Disease.

[62]  A. Beaudet,et al.  Atypical presentation and neuropathological studies in 3‐hydroxy‐3‐methylglutaryl–CoA lyase deficiency , 1986, Annals of neurology.

[63]  O. Søvik,et al.  A child with acute pancreatitis and recurrent hypoglycemia due to 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , 1984, European Journal of Pediatrics.

[64]  E. Owles,et al.  3‐HYDROXY‐3‐METHYLGLUTARYL COENZYME A LYASE DEFICIENCY , 1981, Acta paediatrica Scandinavica.

[65]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[66]  C. B. Ransom,et al.  Astrocytes: multitalented stars of the central nervous system. , 2012, Methods in molecular biology.

[67]  B. Nehru,et al.  Modulatory effects of N-acetylcysteine on cerebral cortex and cerebellum regions of ageing rat brain. , 2007, Nutricion hospitalaria.

[68]  S. Legrand-Poels,et al.  NF-kappaB activation by reactive oxygen species: fifteen years later. , 2006, Biochemical pharmacology.

[69]  H. Bremer,et al.  Neurological manifestations of organic acid disorders , 2005, European Journal of Pediatrics.

[70]  M. Durán,et al.  Group tests for selective screening of inborn errors of metabolism , 2005, European Journal of Pediatrics.

[71]  A. Castoldi,et al.  Biological markers of neurotoxic diseases. , 2001, Functional neurology.

[72]  D. Bredesen,et al.  Cellular resistance to methylmercury. , 1996, Neurotoxicology.

[73]  M. Durán,et al.  Lethal hypoglycemia in a child with a deficiency of 3-hydroxy-3-methylglutarylcoenzyme A lyase. , 1979, The Journal of pediatrics.